The activation effect of antibodies differs depending on the binding site of the disease-causing protein.
Antibodies may have different therapeutic effects depending on which site they bind
to on the diseased protein. NEST (Novel Epitope Screening Technology) is a discovery
platform for antibody treatments that bind to a unique site (epitope) of a disease protein,
and shows a contrasting effect compared to existing antibody treatments. These unique
antibodies developed through NEST also have shown strong synergy effect when used in
combination with existing, commercialized antibody treatments.
